Sun Pharmaceutical Industries has entered into a definitive agreement to acquire Organon for an enterprise valuation of $11.75 billion in... Read more
Category: Uncategorized
Sanofi’s MS therapy secures European endorsement following US rejection
European drug regulators have issued a positive review for Sanofi’s experimental multiple sclerosis (MS) treatment. This move comes after the... Read more
FDA approves Regeneron’s Otarmeni as the first gene therapy for genetic deafness
On April 23, 2026, the US Food and Drug Administration (FDA) authorized Otarmeni (lunsotogene parvec-cwha), the first-ever gene therapy for... Read more
Eli Lilly enters $2.3 billion agreement to acquire Ajax Therapeutics, boosting blood cancer pipeline
Eli Lilly has agreed to acquire Ajax Therapeutics in a deal valued at up to $2.3 billion, featuring an upfront... Read more
Recalled cosmetics continue to be sold openly on e-commerce platforms
Despite explicit recall and destruction orders from the Ministry of Health due to missing Product Information Files (PIF), numerous prohibited... Read more
Ministry of Health proposes new specialized inspection procedures to enhance management transparency
The Ministry of Health is currently seeking public feedback on a draft Circular outlining the authority and procedures for specialized... Read more
Protagonist and J&J secure FDA nod for life-changing oral psoriasis pill
The United States Food and Drug Administration (FDA) has granted approval for icotrokinra, marketed under the brand name ICOTYDE, as... Read more
Plus Therapeutics initiates tech transfer with SpectronRx for CNS radiopharmaceuticals
Plus Therapeutics has begun technology transfer and manufacturing activities at SpectronRx to support late-stage clinical production of Rhenium-186 and Reyobiq... Read more
Regeneron inks White House pricing deal and offers free hearing loss gene therapy
Regeneron Pharmaceuticals has become the 17th major drugmaker to reach a pricing agreement with the Trump administration. Under the "Most... Read more









